ADMET and DMPK最新文献

筛选
英文 中文
Electrochemical sensors for anticancer drugs used in the targeted therapy of chronic myeloid leukaemia. 用于慢性髓性白血病靶向治疗抗癌药物的电化学传感器。
IF 4.3
ADMET and DMPK Pub Date : 2025-07-18 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2825
Totka Dodevska
{"title":"Electrochemical sensors for anticancer drugs used in the targeted therapy of chronic myeloid leukaemia.","authors":"Totka Dodevska","doi":"10.5599/admet.2825","DOIUrl":"10.5599/admet.2825","url":null,"abstract":"<p><strong>Background and purpose: </strong>Treatment of chronic myeloid leukaemia includes targeted therapy with tyrosine kinase inhibitors (TKIs): imatinib, dasatinib, nilotinib, bosutinib, ponatinib, and asciminib. This review aims to prove that electrochemical sensors provide a reliable alternative to the conventional analytical methods for highly sensitive and cost-effective assay of TKIs in pharmaceutical formulations and biofluids. These platforms have significant advantages in fast detection and portability because they could be designed as miniaturized hand-held devices suitable for real-time point-of-care analysis, providing quick results for enabling personalized therapeutic drug monitoring.</p><p><strong>Experimental approach: </strong>The paper covers recent developments in substrate materials, various electrode designs, the advantages, and limitations of sensors for TKIs, encompassing both basic and applied research.</p><p><strong>Key results: </strong>This is a pioneering study that provides a general review on emerging trends, technologies, and practical applications of electrochemical sensors for TKIs analysis. The article provides researchers with a clear introduction and concise guide to the design and application of electrochemical sensors in the clinical analysis of TKIs.</p><p><strong>Conclusion: </strong>The review is intended to serve as a valuable resource for researchers in navigating the latest developments in TKIs' electrochemical sensing platforms. The fast response, high sensitivities and satisfactory recoveries obtained in blood serum and urine samples show the potential for application of the proposed electroanalytical systems in clinical analysis and optimization of chemotherapeutic treatments.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 4","pages":"2825"},"PeriodicalIF":4.3,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nano-modified biosensors for detection of pathogenic diseases: The prospect of smart, multiplex and point-of-care testing. 用于检测致病性疾病的纳米修饰生物传感器:智能、多重和即时检测的前景。
IF 4.3
ADMET and DMPK Pub Date : 2025-07-09 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2799
Abdullahi Umar Ibrahim, Pwadubashiyi Coston Pwavodi, Mehmet Oszoz, Basil Barth Duwa, Irkham Irkham, Yeni Wahyuni Hartati
{"title":"Nano-modified biosensors for detection of pathogenic diseases: The prospect of smart, multiplex and point-of-care testing.","authors":"Abdullahi Umar Ibrahim, Pwadubashiyi Coston Pwavodi, Mehmet Oszoz, Basil Barth Duwa, Irkham Irkham, Yeni Wahyuni Hartati","doi":"10.5599/admet.2799","DOIUrl":"10.5599/admet.2799","url":null,"abstract":"<p><strong>Introduction and background: </strong>The world has witnessed several outbreaks, emergence and re-emergence of infectious diseases throughout the 21<sup>st</sup> century as a result of climate change, urbanization and migration. Several infectious diseases caused by pathogens such as SARS-CoV-2, Ebola, Zika, Dengue, Marburg viruses, <i>Mycobacterium tuberculosis</i>, etc. have caused a devastating impact on lives and livelihoods around the world. To counter these diseases, medical experts rely on conventional techniques, which include microscopy and serological testing. However, these conventional methods are hindered by several trade-offs, including high cost, longer processing times, low sensitivity, and a likelihood of false positive results. Biomedical sensors have gained momentum in clinical diagnostics due to their low cost, portability, and sensitivity, among other advantages. To improve their performance, scientists have incorporated nanomaterials. Other techniques used to enhance the performance of nanobiosensors include multiplex testing, point-of-care testing (POCT), and smart sensing.</p><p><strong>Methodology: </strong>Thus, in this review, we present a comprehensive overview of the state-of-the-art nanobiosensors for detecting infectious diseases. The review covers key topics that are centred around the application of nanotechnology in biosensing, multiplex testing, POCT and smart nano-enhanced biosensors.</p><p><strong>Findings: </strong>The findings of this review highlighted the advantages of biosensors over conventional approaches, with a limit of detection ranging from nanomolar to attomolar concentrations and a time response ranging from 1 to 3 hours.</p><p><strong>Conclusion: </strong>Despite the prospect of nanobiosensors, several limitations exist, including complexity, extensive processing time, and others. Moreover, the integration of smart technologies in nanobiosensors can offer several benefits, including high accuracy and faster detection and prediction.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 4","pages":"2799"},"PeriodicalIF":4.3,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fabrication and optimization of freeze-dried isoniazid-loaded poly-ε-caprolactone nanoparticles. 冷冻干燥负载异烟肼聚ε-己内酯纳米颗粒的制备与优化。
IF 4.3
ADMET and DMPK Pub Date : 2025-07-08 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2774
Eknath Kole, Yuvraj Pawara, Atul Chaudhari, Aniruddha Chatterjee, Jitendra Naik
{"title":"Fabrication and optimization of freeze-dried isoniazid-loaded poly-<i>ε</i>-caprolactone nanoparticles.","authors":"Eknath Kole, Yuvraj Pawara, Atul Chaudhari, Aniruddha Chatterjee, Jitendra Naik","doi":"10.5599/admet.2774","DOIUrl":"10.5599/admet.2774","url":null,"abstract":"<p><strong>Background: </strong>Microfluidic nanoprecipitation followed by freeze-drying would yield uniformly sized, stable nanoparticles by preserving their physicochemical property without compromising therapeutic performance. The isoniazid (INH)-loaded poly-<i>ε</i>-caprolactone (PCL) nanoparticles could be developed using a microfluidic technique for the management of tuberculosis.</p><p><strong>Experimental approach: </strong>The INH-loaded nanoparticles were fabricated via a microreactor-assisted nanoprecipitation method and optimization using a design of experiments factorial design approach. The resulting INH-PCL nanoformulation was characterized for particle size, polydispersity index (PDI), zeta potential (surface charge), Fourier-transform infrared spectroscopy, differential scanning calorimetry, X-ray diffraction analysis and field emission scanning electron microscope.</p><p><strong>Key results: </strong>The optimized nanoparticles exhibited an average particle size (248.4 ± 5.372 nm) and high encapsulation efficiency (82.26 ± 4.36 %). Thermal and spectroscopic analyses confirmed the absence of drug-polymer interactions, ensuring formulation integrity; stability studies under accelerated conditions demonstrated negligible changes in particle size, PDI, and zeta potential over the period of 6 months, indicating robust colloidal stability. A scanning electron microscopy study revealed rod-shaped nanoparticles with smooth surfaces. Lyophilization (freeze-drying) enhanced long-term stability, yielding a readily re-dispersible powder (reconstitution index ~1.066). Following diffusion-controlled kinetics, in vitro drug release studies in phosphate buffer saline (pH 7.4) showed sustained drug release (92.45 % cumulative release over 48 h).</p><p><strong>Conclusion: </strong>Our results confirm that the INH-loaded PCL nanoformulation combines excellent stability, high drug-loading capacity, and sustained release, key attributes of effective tuberculosis therapy.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 4","pages":"2774"},"PeriodicalIF":4.3,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335300/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of lipophilic and size-exclusion membranes: the effect of stirring and cyclodextrin in the donor compartment. 亲脂膜和阻粒膜的比较:搅拌和环糊精对供体隔室的影响。
IF 4.3
ADMET and DMPK Pub Date : 2025-07-05 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2753
Petra Tőzsér, Szabina Kádár, Edina Szabó, Máté Dobó, Gergő Tóth, György T Balogh, Péter Sóti, Bálint Sinkó, Enikő Borbás
{"title":"Comparison of lipophilic and size-exclusion membranes: the effect of stirring and cyclodextrin in the donor compartment.","authors":"Petra Tőzsér, Szabina Kádár, Edina Szabó, Máté Dobó, Gergő Tóth, György T Balogh, Péter Sóti, Bálint Sinkó, Enikő Borbás","doi":"10.5599/admet.2753","DOIUrl":"10.5599/admet.2753","url":null,"abstract":"<p><strong>Background and purpose: </strong>The effective transport of an active pharmaceutical ingredient across various membrane systems is critical for enhancing its bioavailability, especially in formulations involving solubilizing agents. This study aims to investigate the permeability differences of carvedilol (CAR) between lipophilic and size-exclusion membranes in the presence of hydroxypropyl-beta-cyclodextrin (HP-β-CD) using <i>in vitro</i> side-by-side diffusion cell assays.</p><p><strong>Experimental approach: </strong>Solubility and permeability assays confirmed that HP-β-CD significantly enhanced the solubility of CAR, while simultaneously decreasing its permeability, indicating an interplay between the two parameters.</p><p><strong>Key results: </strong>A mathematical model based on Fick's first law of diffusion was developed to describe drug transport across the UWL, and generally through the UWL-membrane system, with a particular focus on the role of solubilizing agents.</p><p><strong>Conclusion: </strong>Results from both the UWL and membrane limited transport conditions demonstrated that the supersaturation ratio (SSR, defined as the ratio of the drug concentration present in solution to its thermodynamic solubility measured in exactly the same media) between donor and acceptor compartments is the real driving force of the transport, when the complexing agent and the drug- HP-β-CD complex does not penetrate the membrane or the permeation of the solubilizing additive through the membrane is relatively slow, so it does not affect the transport of the API substantially.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 4","pages":"2753"},"PeriodicalIF":4.3,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Morphine electrochemical determination using SnO2 nanostructure-modified glassy carbon electrode in the presence of diclofenac. 双氯芬酸存在下,SnO2纳米结构修饰玻碳电极电化学测定吗啡。
IF 4.3
ADMET and DMPK Pub Date : 2025-07-02 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2803
Zainab S Hadawi, Isam Ngaimesh Taeb, Rasha N Aljabery
{"title":"Morphine electrochemical determination using SnO<sub>2</sub> nanostructure-modified glassy carbon electrode in the presence of diclofenac.","authors":"Zainab S Hadawi, Isam Ngaimesh Taeb, Rasha N Aljabery","doi":"10.5599/admet.2803","DOIUrl":"10.5599/admet.2803","url":null,"abstract":"<p><p>In the present work, SnO<sub>2</sub> nanostructures were synthesized and a sensitive voltammetric sensor on a glassy carbon electrode (GCE) was constructed to estimate morphine (MP) in the presence of diclofenac (DLF).</p><p><strong>Background and purpose: </strong>Because diclofenac (DLF) is an NSAID, its administration can reduce postoperative morphine (MP) requirements in adults; for example, standard DLF dosing has been shown to decrease MP use after abdominal surgery. Hence, devising a simple, cost-effective, and swift assay for these compounds in biological and pharmaceutical specimens is indispensable.</p><p><strong>Experimental approach: </strong>SnO<sub>2</sub> nanostructures were synthesized, and a sensitive voltammetric sensor on a glassy carbon electrode (GCE) was constructed to estimate MP in the presence of DLF. Cyclic voltammetry was employed to evaluate the electrochemical response of the SnO2 nanostructures/GCE towards MP.</p><p><strong>Key results: </strong>The SnO<sub>2</sub> nanostructures exhibited a significant effect on the electrochemical reaction of the electrode toward the MP oxidation. The SnO<sub>2</sub> nanostructures/GCE further exhibited a more sensitive detection platform for MP determination with a limit of detection of 0.006 μM using differential pulse voltammetry in a linear range of 0.01 to 340.0 μM.</p><p><strong>Conclusion: </strong>The SnO<sub>2</sub> nanostructures/GCE exhibited extremely high electrochemical activities towards the simultaneous oxidation of MP and DLF. Moreover, the SnO<sub>2</sub> nanostructures/GCE provided reproducible and stable responses for MP quantitation. The platform prepared showed successful performance for MP and DLF determination in real samples. SnO<sub>2</sub> nanostructures exhibited a significant effect on the electrochemical reaction of the electrode toward the MP oxidation. The SnO<sub>2</sub> nanostructures/GCE further exhibited a more sensitive detection platform for MP determination with a limit of detection of 0.006 μM using differential pulse voltammetry in a linear range of 0.01 to 340.0 μM. Additionally, the SnO<sub>2</sub> nanostructures/GCE exhibited extremely high electrochemical activities towards the simultaneous oxidation of MP and DLF. Moreover, the SnO<sub>2</sub> nanostructures/GCE provided reproducible and stable responses for MP quantitation. The platform prepared showed successful performance for MP and DLF determination in real samples.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 4","pages":"2803"},"PeriodicalIF":4.3,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335302/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144815547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simultaneous determination of epinephrine and folic acid using MIL-101 (Fe)-NH2 metal-organic framework/graphene oxide nanocomposite modified electrode. MIL-101 (Fe)-NH2金属-有机骨架/氧化石墨烯纳米复合修饰电极同时测定肾上腺素和叶酸。
IF 3.4
ADMET and DMPK Pub Date : 2025-06-19 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2762
Rasha Kareem Khundhur
{"title":"Simultaneous determination of epinephrine and folic acid using MIL-101 (Fe)-NH<sub>2</sub> metal-organic framework/graphene oxide nanocomposite modified electrode.","authors":"Rasha Kareem Khundhur","doi":"10.5599/admet.2762","DOIUrl":"10.5599/admet.2762","url":null,"abstract":"<p><strong>Background and purpose: </strong>It is generally known that the majority of disorders exhibit symptoms to some degree when the quantities of two crucial substances, epinephrine and folic acid, are low or high. These two chemicals' composition variations may be tracked and utilized to identify conditions such as myocardial infarction, Parkinson's disease, and mental disorders.</p><p><strong>Experimental approach: </strong>Using a solvothermal technique, we propose the synthesis of a novel MIL-101 (Fe)-NH<sub>2</sub> metal-organic framework/graphene oxide nanocomposite (MOF/GO nanocomposite). The produced nanocomposite's morphology was examined using field-emission scanning electron microscopy. A straightforward, quick, and sensitive electrochemical sensing platform for epinephrine detection was then created by drop-casting the produced MOF/GO nanocomposite onto the screen-printed electrode (SPE).</p><p><strong>Key results: </strong>Compared to unmodified SPE, cyclic voltammetry revealed that the MOF/GO/SPE considerably enhanced the epinephrine oxidation process, exhibiting a greater detection current at a lower over-potential. The synergistic combination of MOF and GO sheets may cause this discovery. With a low detection limit of 0.07 μM, the MOF/GO/SPE sensor's linear response for voltammetric measurements of epinephrine was found to be between 0.2 and 500.0 μM. A modified electrode was also utilized to measure folic acid and epinephrine simultaneously.</p><p><strong>Conclusion: </strong>Lastly, the modified SPE effectively demonstrates its high accuracy in identifying folic acid and epinephrine in biological and pharmaceutical samples.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 3","pages":"2762"},"PeriodicalIF":3.4,"publicationDate":"2025-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tuneable carbon dots coated iron oxide nanoparticles as superior T 1 contrast agent for multimodal imaging. 可调谐碳点包覆氧化铁纳米颗粒作为多模态成像的卓越t1造影剂。
IF 3.4
ADMET and DMPK Pub Date : 2025-06-18 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2790
Anbazhagan Thirumalai, Palani Sharmiladevi, Koyeli Girigoswami, Alex Daniel Prabhu, Agnishwar Girigoswami
{"title":"Tuneable carbon dots coated iron oxide nanoparticles as superior <i>T</i> <sub>1</sub> contrast agent for multimodal imaging.","authors":"Anbazhagan Thirumalai, Palani Sharmiladevi, Koyeli Girigoswami, Alex Daniel Prabhu, Agnishwar Girigoswami","doi":"10.5599/admet.2790","DOIUrl":"10.5599/admet.2790","url":null,"abstract":"<p><strong>Background and purpose: </strong>Multifunctional hybrid nanoparticles garner heightened interest for prospective biomedical applications, including medical imaging and medication administration, owing to their synergistic benefits of constituent components. Therefore, we demonstrated an optimized protocol for synthesizing magnetofluorescent nanohybrids comprising fluorescent carbon dots with magnetic nanoparticles.</p><p><strong>Experimental approach: </strong>Carbon dot-coated iron oxide nanoparticles (CDs@Fe<sub>2</sub>O<sub>3</sub>) were synthesized with varying citric acid concentrations by a one-pot hydrothermal synthesis method for the development of a low-cost and biocompatible contrast agent (CA) for enhanced multimodal imaging (fluorescent and <i>T</i> <sub>1</sub> and <i>T</i> <sub>2</sub> weighted magnetic resonance imaging (MRI)) to replace the conventional CAs.</p><p><strong>Key results: </strong>The physicochemical characterization of the synthesized CDs@Fe<sub>2</sub>O<sub>3</sub> revealed that 3 g of citric acid used for the synthesis of nanoparticles, keeping Fe(II) and Fe(III) ratio 1:2 provides higher stability of -78 mV zeta potential, saturation magnetization of 24 emu/g, with a hydrodynamic diameter of 68 nm. Carbon coating affects surface spins on Fe<sub>2</sub>O<sub>3</sub>, resulting in fewer surface-based relaxation centres, making <i>T</i> <sub>1</sub> relaxation relatively more prominent. Furthermore, the surface-engineered iron oxide NPs are efficient in producing both <i>T</i> <sub>1</sub> and <i>T</i> <sub>2</sub> weighted MRI as well as fluorescence-based imaging. The molar relaxivity and molar radiant efficiency derived from phantom studies demonstrate their effectiveness in multimodal medical imaging. The cytotoxicity assay, haemolysis assay, haematology, and histopathology studies show that the optimized CDs@Fe<sub>2</sub>O<sub>3</sub> are biocompatible, haemocompatible, and negligibly toxic.</p><p><strong>Conclusion: </strong>We can conclude the significant potency of CDs@Fe<sub>2</sub>O<sub>3</sub> for multimodal diagnosis.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 3","pages":"2790"},"PeriodicalIF":3.4,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205923/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRISPR-Cas9-based electrochemical biosensor for the detection of katG gene mutations in isoniazid-resistant tuberculosis. 基于crispr - cas9的电化学生物传感器检测异烟肼耐药结核中katG基因突变。
IF 3.4
ADMET and DMPK Pub Date : 2025-06-17 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2766
Dika Apriliana Wulandari, Muhammad Ihda Hamlu Liwaissunati Zein, Salma Nur Zakiyyah, Safri Ishmayana, Mehmet Ozsoz, Yeni Wahyuni Hartati, Irkham
{"title":"CRISPR-Cas9-based electrochemical biosensor for the detection of <i>katG</i> gene mutations in isoniazid-resistant tuberculosis.","authors":"Dika Apriliana Wulandari, Muhammad Ihda Hamlu Liwaissunati Zein, Salma Nur Zakiyyah, Safri Ishmayana, Mehmet Ozsoz, Yeni Wahyuni Hartati, Irkham","doi":"10.5599/admet.2766","DOIUrl":"10.5599/admet.2766","url":null,"abstract":"<p><strong>Background and purpose: </strong>Multidrug-resistant tuberculosis (MDR-TB) remains a significant challenge in tuberculosis (TB) treatment, driven by simultaneous mutations in the <i>rpoB</i> and <i>katG</i> genes that confer resistance to rifampicin and isoniazid. While many molecular diagnostic tools focus on <i>rpoB</i>, the <i>katG</i> gene is often overlooked despite its critical role in confirming MDR-TB. This study aims to develop a CRISPR/Cas9-based electrochemical biosensor for the rapid and selective detection of <i>katG</i> mutation.</p><p><strong>Experimental approach: </strong>A guide RNA (gRNA) specific to the mutation site on <i>katG</i> gene was designed using the Benchling CRISPR tool, considering on-target and off-target scores, specificity, and cleavage sites within the <i>Mycobacterium tuberculosis</i> genome. The selected gRNA achieved the highest on-target score of 61.2 and an off-target score of 49.0 at cut position 2928, with a PAM sequence of AGG. Its cleavage efficiency was validated experimentally using an electrochemical biosensing platform incorporating a gold-modified screen-printed carbon electrode (SPCE/Au). Redox response enhancement by [Fe(CN<sub>6</sub>)]<sup>3-/4-</sup> confirmed the improved performance of the electrode.</p><p><strong>Key results: </strong>The biosensor system detects the target DNA through hybridization with DNA probe-Fc, forming double-stranded DNA (dsDNA) that is recognized and cleaved by the Cas9/gRNA complex. This cleavage significantly reduces the ferrocene oxidation signal, indicating the presence of a <i>katG</i> mutation. Non-mutated target DNA produces a nondetectable ferrocene signal, suggesting that the Cas9 enzyme may remain bound to the electrode without cleavage. The CRISPR/Cas9 electrochemical biosensor demonstrated a low detection limit of 7.5530 aM and a detection range of 10<sup>1</sup> to 10<sup>6</sup> aM.</p><p><strong>Conclusion: </strong>The CRISPR/Cas9-based electrochemical biosensor exhibits high sensitivity and specificity for the detection <i>katG</i> mutation, offering a promising platform for rapid MDR-TB diagnostics.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 3","pages":"2766"},"PeriodicalIF":3.4,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144525995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between A3243G and G9053A mtDNA mutations and ATP levels in diabetes mellitus patients using qPCR and electrochemical aptasensors. 应用qPCR和电化学适配体传感器研究糖尿病患者A3243G和G9053A mtDNA突变与ATP水平的相关性
IF 3.4
ADMET and DMPK Pub Date : 2025-06-12 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2767
Iman Permana Maksum, Rahmaniar Mulyani, Yeni Wahyuni Hartati, Irkham, Fanny Rizki Rahmadanthi, Serly Zuliska, Toto Subroto
{"title":"Correlation between A3243G and G9053A mtDNA mutations and ATP levels in diabetes mellitus patients using qPCR and electrochemical aptasensors.","authors":"Iman Permana Maksum, Rahmaniar Mulyani, Yeni Wahyuni Hartati, Irkham, Fanny Rizki Rahmadanthi, Serly Zuliska, Toto Subroto","doi":"10.5599/admet.2767","DOIUrl":"10.5599/admet.2767","url":null,"abstract":"<p><strong>Background and purpose: </strong>Mitochondrial DNA (mtDNA) mutations can impair oxidative phosphorylation and ATP production, potentially contributing to the pathogenesis of type 2 diabetes mellitus (T2DM). This study aimed to investigate the relationship between mtDNA mutations and ATP levels in blood and urine samples from T2DM patients.</p><p><strong>Experimental approach: </strong>Samples from 60 patients (30 with T2DM + mitochondrial disease [MD] phenotype and 30 with T2DM alone) were analysed. mtDNA mutations A3243G and G9053A were detected using qPCR with dual-labeled probes (FAM for mutant, HEX for wild type) based on <i>C</i>q comparisons. ATP concentrations were measured using a screen-printed carbon electrode (SPCE)-based electrochemical aptasensor.</p><p><strong>Key results: </strong>The A3243G mutation was more frequent and had higher heteroplasmy levels than G9053A, particularly in the T2DM + MD group. Although no statistically significant differences in ATP levels were observed between groups, descriptive ranges showed lower ATP concentrations in the T2DM + MD group (314 to 919 μM) compared to the T2DM group (746 to 1130 μM), both below the physiological range (1.500 to 1.900 μM). A similar pattern was found for A3243G mutation levels, while G9053A levels overlapped between groups. Two-way ANOVA showed a significant association between mutation presence and reduced ATP levels.</p><p><strong>Conclusion: </strong>The A3243G mutation may be more directly associated with mitochondrial ATP depletion in T2DM, while the role of G9053A remains inconclusive. This study highlights the potential of combining molecular and electrochemical tools to assess mitochondrial contributions in diabetes.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 3","pages":"2767"},"PeriodicalIF":3.4,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144525994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic insights into the warfarin-mango interaction: A pilot study integrating clinical observations and metabolomics. 代谢洞察华法林-芒果相互作用:一项结合临床观察和代谢组学的初步研究。
IF 3.4
ADMET and DMPK Pub Date : 2025-06-08 eCollection Date: 2025-01-01 DOI: 10.5599/admet.2740
Piyapat Rattanasuwan, Prem Lertpongpipat, Natthapat Hiranchatchawal, Konwalin Wannaphueak, Sakonwan Pounghom, Parinya Thongkhao-On, Matchuda Suwanthai, Duangthip Sompradee, Auiporn Saithongdee, Churdsak Jaikang, Preechaya Tajai
{"title":"Metabolic insights into the warfarin-mango interaction: A pilot study integrating clinical observations and metabolomics.","authors":"Piyapat Rattanasuwan, Prem Lertpongpipat, Natthapat Hiranchatchawal, Konwalin Wannaphueak, Sakonwan Pounghom, Parinya Thongkhao-On, Matchuda Suwanthai, Duangthip Sompradee, Auiporn Saithongdee, Churdsak Jaikang, Preechaya Tajai","doi":"10.5599/admet.2740","DOIUrl":"10.5599/admet.2740","url":null,"abstract":"<p><strong>Background and purpose: </strong>Warfarin is a widely prescribed oral anticoagulant for the prevention and treatment of thromboembolic events, frequently used in patients with atrial fibrillation. However, its effectiveness is often challenged by a narrow therapeutic range and significant inter-patient variability in dosage requirements and treatment responses. Drug interactions remain a critical concern, as they heighten the risk of supratherapeutic anticoagulation. Reports of interactions between warfarin and mango have documented cases of elevated international normalized ratio (INR) following mango consumption, although the underlying molecular mechanisms remain unclear.</p><p><strong>Experimental approach: </strong>This study investigates the molecular basis of the warfarin-mango interaction using proton nuclear magnetic resonance (<sup>1</sup>H-NMR)-based metabolomics. In a pre-post design study, plasma samples were collected from patients on long-term warfarin therapy (>6 months) who exhibited supratherapeutic INR levels after consuming mango. After a two-week discontinuation of mango consumption, additional plasma samples were collected once INR levels returned to the therapeutic range.</p><p><strong>Key results and conclusion: </strong>This is the first study to utilize <sup>1</sup>H-NMR metabolomics to explore warfarin-mango interactions, integrating clinical observations with metabolic insights. Findings suggest that a reduction in glycerol 3-phosphate may impair glycolysis, disrupting platelet activation and contributing to the elevated INR levels observed in all patients. These results underscore the potential for <sup>1</sup>H-NMR metabolomics to elucidate drug-food interactions, advancing personalized anticoagulant management and improving patient safety.</p>","PeriodicalId":7259,"journal":{"name":"ADMET and DMPK","volume":"13 3","pages":"2740"},"PeriodicalIF":3.4,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144526009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书